top of page
Create Your First Project
Start adding your projects to your portfolio. Click on "Manage Projects" to get started
Hereditary angioedema in vivo CRISPR treatment clears Phase III, receives BLA approval - BioXconomy
Date
October 1, 2026
Link
The one-dose genome editing therapy would transform the treatment landscape for patients dealing with a life-threatening and unpredictable disease.
bottom of page